Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism – translating the pharmacology

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|84|2|252-267

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.84, Iss.2, 2018-02, pp. : 252-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parathyroid hormone analogues in the therapy of osteoporosis

By Müller Markus   Pietschmann Peter  

Wiener klinische Wochenschrift, Vol. 120, Iss. 11-12, 2008-06 ,pp. : 321-324

Springer Publishing Company

Access to resources Recommend Favorite

Therapy of hypoparathyroidism with intact parathyroid hormone

By Rubin M.   Sliney J.   McMahon D.   Silverberg S.   Bilezikian J.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1927-1934

Springer Publishing Company

Access to resources Recommend Favorite

Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 262-271

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of parathyroid hormone as anabolic therapy for osteoporosis: A timeline

By Dempster David   Reeve Jonathan  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 4, 2006-12 ,pp. : 227-231

Humana Press, Inc

Access to resources Recommend Favorite

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite